

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sulfation (GO:0051923) | 3.97484229 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.59074902 |
| 3 | negative regulation of cell killing (GO:0031342) | 3.51262836 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.51262836 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.42761599 |
| 6 | presynaptic membrane assembly (GO:0097105) | 3.34270993 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32076830 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.30755928 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.22885159 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 3.22640582 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.19144423 |
| 12 | interferon-gamma secretion (GO:0072643) | 3.14889749 |
| 13 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.12454625 |
| 14 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.11581145 |
| 15 | vocalization behavior (GO:0071625) | 3.09869204 |
| 16 | positive regulation of fatty acid oxidation (GO:0046321) | 3.08832803 |
| 17 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.07452418 |
| 18 | modulation by virus of host process (GO:0019054) | 3.01699525 |
| 19 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.01175981 |
| 20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00167646 |
| 21 | positive regulation of histone deacetylation (GO:0031065) | 2.98059625 |
| 22 | response to type I interferon (GO:0034340) | 2.95501510 |
| 23 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94398408 |
| 24 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.93207266 |
| 25 | response to peptidoglycan (GO:0032494) | 2.92136555 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 2.90784880 |
| 27 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.90132188 |
| 28 | modulation by symbiont of host cellular process (GO:0044068) | 2.89440372 |
| 29 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.87339723 |
| 30 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.87339723 |
| 31 | modulation by symbiont of host immune response (GO:0052553) | 2.87339723 |
| 32 | positive regulation by symbiont of host defense response (GO:0052509) | 2.87339723 |
| 33 | modulation by symbiont of host defense response (GO:0052031) | 2.87339723 |
| 34 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.87339723 |
| 35 | immunoglobulin mediated immune response (GO:0016064) | 2.84856014 |
| 36 | negative T cell selection (GO:0043383) | 2.84812519 |
| 37 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.84706612 |
| 38 | locomotory exploration behavior (GO:0035641) | 2.83292844 |
| 39 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.82730725 |
| 40 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.82711899 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 2.82547228 |
| 42 | serotonin receptor signaling pathway (GO:0007210) | 2.82516107 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.79096236 |
| 44 | positive regulation of mast cell activation (GO:0033005) | 2.78234299 |
| 45 | cellular response to type I interferon (GO:0071357) | 2.77633247 |
| 46 | type I interferon signaling pathway (GO:0060337) | 2.77633247 |
| 47 | negative thymic T cell selection (GO:0045060) | 2.76835225 |
| 48 | positive T cell selection (GO:0043368) | 2.74179678 |
| 49 | histone H3-K36 demethylation (GO:0070544) | 2.71185238 |
| 50 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.70975705 |
| 51 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.70915292 |
| 52 | L-amino acid import (GO:0043092) | 2.70782986 |
| 53 | germinal center formation (GO:0002467) | 2.70178814 |
| 54 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.70146310 |
| 55 | mature B cell differentiation (GO:0002335) | 2.68749386 |
| 56 | presynaptic membrane organization (GO:0097090) | 2.67872597 |
| 57 | regulation of germinal center formation (GO:0002634) | 2.66472642 |
| 58 | regulation of memory T cell differentiation (GO:0043380) | 2.65030515 |
| 59 | regulation of regulatory T cell differentiation (GO:0045589) | 2.64981297 |
| 60 | regulation of platelet aggregation (GO:0090330) | 2.63869033 |
| 61 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.63865306 |
| 62 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.63179695 |
| 63 | T cell selection (GO:0045058) | 2.62633663 |
| 64 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.61593330 |
| 65 | positive regulation of interferon-alpha production (GO:0032727) | 2.61268877 |
| 66 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61187925 |
| 67 | response to interleukin-15 (GO:0070672) | 2.60769913 |
| 68 | tolerance induction (GO:0002507) | 2.59982221 |
| 69 | T cell migration (GO:0072678) | 2.59646637 |
| 70 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.59191398 |
| 71 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.59099756 |
| 72 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.58838927 |
| 73 | activated T cell proliferation (GO:0050798) | 2.58738714 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.58286835 |
| 75 | response to host immune response (GO:0052572) | 2.58286835 |
| 76 | detection of other organism (GO:0098543) | 2.57972065 |
| 77 | negative regulation of interleukin-12 production (GO:0032695) | 2.57910725 |
| 78 | regulation of mast cell activation (GO:0033003) | 2.55864142 |
| 79 | G-protein coupled receptor internalization (GO:0002031) | 2.54766699 |
| 80 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.54503688 |
| 81 | startle response (GO:0001964) | 2.54015349 |
| 82 | cellular extravasation (GO:0045123) | 2.53179814 |
| 83 | mannose metabolic process (GO:0006013) | 2.52383210 |
| 84 | detection of bacterium (GO:0016045) | 2.51134058 |
| 85 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.51108560 |
| 86 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.50929456 |
| 87 | response to host (GO:0075136) | 2.50929456 |
| 88 | response to host defenses (GO:0052200) | 2.50929456 |
| 89 | synaptic transmission, glutamatergic (GO:0035249) | 2.49149093 |
| 90 | regulation of interferon-alpha production (GO:0032647) | 2.48828502 |
| 91 | neuron-neuron synaptic transmission (GO:0007270) | 2.46065707 |
| 92 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.45424120 |
| 93 | adaptation of signaling pathway (GO:0023058) | 2.45013754 |
| 94 | Golgi to endosome transport (GO:0006895) | 2.44752150 |
| 95 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.44629596 |
| 96 | glycosphingolipid biosynthetic process (GO:0006688) | 2.43476645 |
| 97 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.43453932 |
| 98 | regulation of Rap GTPase activity (GO:0032317) | 2.42883389 |
| 99 | import into cell (GO:0098657) | 2.41938981 |
| 100 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.41032299 |
| 101 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.40061983 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 2.38485726 |
| 103 | neutrophil activation (GO:0042119) | 2.38065706 |
| 104 | myeloid cell activation involved in immune response (GO:0002275) | 2.38030454 |
| 105 | regulation of mast cell degranulation (GO:0043304) | 2.37978578 |
| 106 | detection of external biotic stimulus (GO:0098581) | 2.35854119 |
| 107 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.34953278 |
| 108 | negative regulation of protein oligomerization (GO:0032460) | 2.34743373 |
| 109 | negative regulation of T cell mediated immunity (GO:0002710) | 2.34713701 |
| 110 | long-term memory (GO:0007616) | 2.34398372 |
| 111 | histone H3-K4 trimethylation (GO:0080182) | 2.33798168 |
| 112 | long-term synaptic potentiation (GO:0060291) | 2.33770584 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.33603144 |
| 114 | thymic T cell selection (GO:0045061) | 2.33302859 |
| 115 | neuron recognition (GO:0008038) | 2.33228042 |
| 116 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.30643071 |
| 117 | microglial cell activation (GO:0001774) | 2.29622855 |
| 118 | B cell receptor signaling pathway (GO:0050853) | 2.29299613 |
| 119 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.28696730 |
| 120 | negative regulation of B cell mediated immunity (GO:0002713) | 2.28696730 |
| 121 | nerve growth factor signaling pathway (GO:0038180) | 2.28495433 |
| 122 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.28219541 |
| 123 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.27077873 |
| 124 | positive thymic T cell selection (GO:0045059) | 2.26492740 |
| 125 | negative regulation of type 2 immune response (GO:0002829) | 2.25252896 |
| 126 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.24699911 |
| 127 | neutrophil mediated immunity (GO:0002446) | 2.24616114 |
| 128 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.24508696 |
| 129 | response to protozoan (GO:0001562) | 2.24503566 |
| 130 | leukocyte aggregation (GO:0070486) | 2.24499397 |
| 131 | regulation of synaptic vesicle transport (GO:1902803) | 2.23803078 |
| 132 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.23612903 |
| 133 | T-helper cell differentiation (GO:0042093) | 2.23612903 |
| 134 | regulation of interferon-beta production (GO:0032648) | 2.23425344 |
| 135 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.23383833 |
| 136 | granulocyte activation (GO:0036230) | 2.22858304 |
| 137 | neuronal action potential propagation (GO:0019227) | 2.22685176 |
| 138 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.22681530 |
| 139 | macrophage activation involved in immune response (GO:0002281) | 2.22334102 |
| 140 | response to pheromone (GO:0019236) | 2.22057268 |
| 141 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.21904531 |
| 142 | positive regulation of protein deacetylation (GO:0090312) | 2.21854365 |
| 143 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.21812077 |
| 144 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.21388725 |
| 145 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.20315924 |
| 146 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.20261688 |
| 147 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.20195100 |
| 148 | NIK/NF-kappaB signaling (GO:0038061) | 2.20181398 |
| 149 | defense response to protozoan (GO:0042832) | 2.20118072 |
| 150 | cellular response to ATP (GO:0071318) | 2.20084913 |
| 151 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.19590112 |
| 152 | negative regulation of exocytosis (GO:0045920) | 2.19557556 |
| 153 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.19368815 |
| 154 | axonal fasciculation (GO:0007413) | 2.19136533 |
| 155 | cellular potassium ion homeostasis (GO:0030007) | 2.18869122 |
| 156 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.18858686 |
| 157 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.18233150 |
| 158 | positive regulation of antigen processing and presentation (GO:0002579) | 2.14233081 |
| 159 | protein localization to synapse (GO:0035418) | 2.13497140 |
| 160 | transmission of nerve impulse (GO:0019226) | 2.12671740 |
| 161 | synaptic vesicle endocytosis (GO:0048488) | 2.11964607 |
| 162 | opioid receptor signaling pathway (GO:0038003) | 2.11295550 |
| 163 | postsynaptic membrane organization (GO:0001941) | 2.10656557 |
| 164 | lens fiber cell differentiation (GO:0070306) | 2.10101038 |
| 165 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.09888811 |
| 166 | negative regulation of neurotransmitter transport (GO:0051589) | 2.09639922 |
| 167 | neutrophil activation involved in immune response (GO:0002283) | 2.08898440 |
| 168 | positive regulation of Rap GTPase activity (GO:0032854) | 2.07221756 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.85928529 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.08973250 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.17048499 |
| 4 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.75741496 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38383994 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34487761 |
| 7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.34330778 |
| 8 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.27860894 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.16501736 |
| 10 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.13323274 |
| 11 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10733584 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.98357890 |
| 13 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.95726278 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 1.92447168 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.86310210 |
| 16 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.86249575 |
| 17 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.85854285 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.84878426 |
| 19 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.81829301 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.80051553 |
| 21 | * TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.79203931 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.75267370 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.72907901 |
| 24 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.72083006 |
| 25 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.71767480 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.71555562 |
| 27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.68918135 |
| 28 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.68069724 |
| 29 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.67279701 |
| 30 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.66253299 |
| 31 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.65757801 |
| 32 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.65757801 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.64877841 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.64877127 |
| 35 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.64150947 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.62312635 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61803210 |
| 38 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60413427 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.60121585 |
| 40 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.59991966 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.58554030 |
| 42 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.58490417 |
| 43 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57747587 |
| 44 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.57565151 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.55907215 |
| 46 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.55064297 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.54326044 |
| 48 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.51450494 |
| 49 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.51193564 |
| 50 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49489072 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47688122 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.47263648 |
| 53 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46806074 |
| 54 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.43592657 |
| 55 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.42168777 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.41925606 |
| 57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.41403008 |
| 58 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.40864848 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.40486656 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40403052 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.39791531 |
| 62 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39259692 |
| 63 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38540504 |
| 64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38530634 |
| 65 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.37024425 |
| 66 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.35289032 |
| 67 | MAF_26560356_Chip-Seq_TH1_Human | 1.35185133 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.35129523 |
| 69 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.34655270 |
| 70 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.34063893 |
| 71 | UTX_26944678_Chip-Seq_JUKART_Human | 1.32840866 |
| 72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32181525 |
| 73 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.28528447 |
| 74 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27646116 |
| 75 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.25708656 |
| 76 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24450681 |
| 77 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.23739849 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23265129 |
| 79 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22931141 |
| 80 | MYB_26560356_Chip-Seq_TH2_Human | 1.21902995 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.21279135 |
| 82 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21082295 |
| 83 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21082295 |
| 84 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20704935 |
| 85 | TCF4_23295773_ChIP-Seq_U87_Human | 1.20460309 |
| 86 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20046627 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19322646 |
| 88 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.19318880 |
| 89 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.18763308 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18711971 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.18514729 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.16920769 |
| 93 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.16842765 |
| 94 | MYB_26560356_Chip-Seq_TH1_Human | 1.16701833 |
| 95 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.16530293 |
| 96 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15582471 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15545528 |
| 98 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.15179109 |
| 99 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.14305355 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14056331 |
| 101 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.13501555 |
| 102 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.13179503 |
| 103 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.13039647 |
| 104 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.12463445 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11687636 |
| 106 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.11576793 |
| 107 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11058035 |
| 108 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10805591 |
| 109 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10632164 |
| 110 | AR_25329375_ChIP-Seq_VCAP_Human | 1.10377518 |
| 111 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10349806 |
| 112 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10185402 |
| 113 | AR_19668381_ChIP-Seq_PC3_Human | 1.09962223 |
| 114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09634163 |
| 115 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06540174 |
| 116 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.06196879 |
| 117 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05820583 |
| 118 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.05291466 |
| 119 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04961092 |
| 120 | MAF_26560356_Chip-Seq_TH2_Human | 1.04817060 |
| 121 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04271102 |
| 122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.04184318 |
| 123 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04120340 |
| 124 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03873171 |
| 125 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03379549 |
| 126 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.02900955 |
| 127 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02618022 |
| 128 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01988268 |
| 129 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.01779761 |
| 130 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01187295 |
| 131 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.00996583 |
| 132 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.00331415 |
| 133 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.00328442 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99996043 |
| 135 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.99766524 |
| 136 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99461251 |
| 137 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.99427231 |
| 138 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99194177 |
| 139 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.98820338 |
| 140 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.98784599 |
| 141 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97611963 |
| 142 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.97346001 |
| 143 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96294201 |
| 144 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.96059243 |
| 145 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.95962181 |
| 146 | GATA3_26560356_Chip-Seq_TH2_Human | 0.95821913 |
| 147 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92820239 |
| 148 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92134963 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91098963 |
| 150 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90944517 |
| 151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.87942322 |
| 152 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87407680 |
| 153 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.86320274 |
| 154 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85217743 |
| 155 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83067688 |
| 156 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.82465470 |
| 157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81783286 |
| 158 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81169519 |
| 159 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.80850847 |
| 160 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.80725940 |
| 161 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80366471 |
| 162 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.79325756 |
| 163 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.78655223 |
| 164 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78375412 |
| 165 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.77772168 |
| 166 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.76255207 |
| 167 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.75790013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.61644658 |
| 2 | MP0002735_abnormal_chemical_nociception | 3.26741583 |
| 3 | MP0003880_abnormal_central_pattern | 2.98557957 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 2.94112192 |
| 5 | MP0003724_increased_susceptibility_to | 2.82580412 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.35889976 |
| 7 | MP0005387_immune_system_phenotype | 2.33143960 |
| 8 | MP0001790_abnormal_immune_system | 2.33143960 |
| 9 | MP0005310_abnormal_salivary_gland | 2.29987326 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.28245668 |
| 11 | MP0009745_abnormal_behavioral_response | 2.11026627 |
| 12 | MP0003787_abnormal_imprinting | 2.10245648 |
| 13 | MP0001501_abnormal_sleep_pattern | 2.04930375 |
| 14 | MP0002063_abnormal_learning/memory/cond | 2.02621497 |
| 15 | MP0002736_abnormal_nociception_after | 2.01494677 |
| 16 | MP0010386_abnormal_urinary_bladder | 2.00033888 |
| 17 | MP0002064_seizures | 1.99016481 |
| 18 | MP0004270_analgesia | 1.97926627 |
| 19 | MP0004510_myositis | 1.96787587 |
| 20 | MP0004043_abnormal_pH_regulation | 1.96246215 |
| 21 | MP0001486_abnormal_startle_reflex | 1.96098996 |
| 22 | MP0002572_abnormal_emotion/affect_behav | 1.86979407 |
| 23 | MP0005645_abnormal_hypothalamus_physiol | 1.86713652 |
| 24 | MP0003183_abnormal_peptide_metabolism | 1.86028945 |
| 25 | MP0005423_abnormal_somatic_nervous | 1.85602198 |
| 26 | MP0005671_abnormal_response_to | 1.78961797 |
| 27 | MP0001346_abnormal_lacrimal_gland | 1.77919466 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.77418819 |
| 29 | MP0009046_muscle_twitch | 1.76241448 |
| 30 | MP0005167_abnormal_blood-brain_barrier | 1.75063933 |
| 31 | MP0005409_darkened_coat_color | 1.74855913 |
| 32 | MP0002163_abnormal_gland_morphology | 1.73983954 |
| 33 | MP0001800_abnormal_humoral_immune | 1.73167129 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.71970233 |
| 35 | MP0004947_skin_inflammation | 1.67679532 |
| 36 | MP0001529_abnormal_vocalization | 1.67312995 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.66797773 |
| 38 | MP0004742_abnormal_vestibular_system | 1.64695125 |
| 39 | MP0000685_abnormal_immune_system | 1.64234226 |
| 40 | MP0005000_abnormal_immune_tolerance | 1.61905317 |
| 41 | MP0002272_abnormal_nervous_system | 1.61136956 |
| 42 | MP0002734_abnormal_mechanical_nocicepti | 1.59267202 |
| 43 | MP0008872_abnormal_physiological_respon | 1.57089231 |
| 44 | MP0002067_abnormal_sensory_capabilities | 1.55304820 |
| 45 | MP0010155_abnormal_intestine_physiology | 1.53437281 |
| 46 | MP0002452_abnormal_antigen_presenting | 1.49748372 |
| 47 | MP0005379_endocrine/exocrine_gland_phen | 1.44973058 |
| 48 | MP0004858_abnormal_nervous_system | 1.43912594 |
| 49 | MP0003303_peritoneal_inflammation | 1.43683135 |
| 50 | MP0002723_abnormal_immune_serum | 1.43151690 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.42894026 |
| 52 | MP0002419_abnormal_innate_immunity | 1.42623267 |
| 53 | MP0004883_abnormal_blood_vessel | 1.41913488 |
| 54 | MP0001819_abnormal_immune_cell | 1.41722638 |
| 55 | MP0002928_abnormal_bile_duct | 1.41397880 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.41148563 |
| 57 | MP0001502_abnormal_circadian_rhythm | 1.40955742 |
| 58 | MP0002089_abnormal_postnatal_growth/wei | 1.40257372 |
| 59 | MP0001970_abnormal_pain_threshold | 1.39961117 |
| 60 | MP0000778_abnormal_nervous_system | 1.37837080 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.37141768 |
| 62 | MP0001533_abnormal_skeleton_physiology | 1.36762929 |
| 63 | MP0008569_lethality_at_weaning | 1.35863759 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.35733851 |
| 65 | MP0000566_synostosis | 1.31782981 |
| 66 | MP0001485_abnormal_pinna_reflex | 1.28392312 |
| 67 | MP0002653_abnormal_ependyma_morphology | 1.27133126 |
| 68 | MP0004381_abnormal_hair_follicle | 1.25773612 |
| 69 | MP0002733_abnormal_thermal_nociception | 1.25657366 |
| 70 | MP0000689_abnormal_spleen_morphology | 1.25456345 |
| 71 | MP0002557_abnormal_social/conspecific_i | 1.23996618 |
| 72 | MP0003172_abnormal_lysosome_physiology | 1.23423355 |
| 73 | MP0000920_abnormal_myelination | 1.20555842 |
| 74 | MP0002148_abnormal_hypersensitivity_rea | 1.19278072 |
| 75 | MP0005646_abnormal_pituitary_gland | 1.19009067 |
| 76 | MP0001873_stomach_inflammation | 1.18760636 |
| 77 | MP0002139_abnormal_hepatobiliary_system | 1.18352332 |
| 78 | MP0001984_abnormal_olfaction | 1.18097823 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.15531588 |
| 80 | MP0002398_abnormal_bone_marrow | 1.14405636 |
| 81 | MP0001851_eye_inflammation | 1.13654902 |
| 82 | MP0005025_abnormal_response_to | 1.13269601 |
| 83 | MP0005076_abnormal_cell_differentiation | 1.12562224 |
| 84 | MP0002184_abnormal_innervation | 1.12451932 |
| 85 | MP0002102_abnormal_ear_morphology | 1.12445561 |
| 86 | MP0004924_abnormal_behavior | 1.11575915 |
| 87 | MP0005386_behavior/neurological_phenoty | 1.11575915 |
| 88 | MP0008260_abnormal_autophagy | 1.11318112 |
| 89 | MP0000716_abnormal_immune_system | 1.10618728 |
| 90 | MP0008961_abnormal_basal_metabolism | 1.10194749 |
| 91 | MP0003763_abnormal_thymus_physiology | 1.09402944 |
| 92 | MP0009764_decreased_sensitivity_to | 1.09240871 |
| 93 | MP0000015_abnormal_ear_pigmentation | 1.08163238 |
| 94 | MP0001188_hyperpigmentation | 1.07996268 |
| 95 | MP0003136_yellow_coat_color | 1.07218045 |
| 96 | MP0009785_altered_susceptibility_to | 1.06529676 |
| 97 | MP0002429_abnormal_blood_cell | 1.04126055 |
| 98 | MP0003436_decreased_susceptibility_to | 1.03763307 |
| 99 | MP0009278_abnormal_bone_marrow | 1.03610924 |
| 100 | MP0000703_abnormal_thymus_morphology | 1.02696021 |
| 101 | MP0005174_abnormal_tail_pigmentation | 1.02390983 |
| 102 | MP0002132_abnormal_respiratory_system | 1.02383217 |
| 103 | MP0004134_abnormal_chest_morphology | 1.01674728 |
| 104 | MP0001663_abnormal_digestive_system | 1.01214287 |
| 105 | MP0002722_abnormal_immune_system | 0.99320784 |
| 106 | MP0006292_abnormal_olfactory_placode | 0.97190081 |
| 107 | MP0000371_diluted_coat_color | 0.96332883 |
| 108 | MP0008469_abnormal_protein_level | 0.95498609 |
| 109 | MP0003690_abnormal_glial_cell | 0.95488986 |
| 110 | MP0001765_abnormal_ion_homeostasis | 0.95212231 |
| 111 | MP0000631_abnormal_neuroendocrine_gland | 0.94166944 |
| 112 | MP0003091_abnormal_cell_migration | 0.93681583 |
| 113 | MP0003329_amyloid_beta_deposits | 0.92353291 |
| 114 | MP0004142_abnormal_muscle_tone | 0.91641761 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.89950671 |
| 116 | MP0009840_abnormal_foam_cell | 0.87646921 |
| 117 | MP0006082_CNS_inflammation | 0.87573206 |
| 118 | MP0001963_abnormal_hearing_physiology | 0.83941380 |
| 119 | MP0002066_abnormal_motor_capabilities/c | 0.83122334 |
| 120 | MP0006276_abnormal_autonomic_nervous | 0.81753585 |
| 121 | MP0005164_abnormal_response_to | 0.81566065 |
| 122 | MP0003045_fibrosis | 0.81516787 |
| 123 | MP0002405_respiratory_system_inflammati | 0.80074040 |
| 124 | MP0009333_abnormal_splenocyte_physiolog | 0.80072950 |
| 125 | MP0004885_abnormal_endolymph | 0.80053208 |
| 126 | MP0002882_abnormal_neuron_morphology | 0.79549701 |
| 127 | MP0005166_decreased_susceptibility_to | 0.79518775 |
| 128 | MP0005464_abnormal_platelet_physiology | 0.79467903 |
| 129 | MP0002822_catalepsy | 0.79002674 |
| 130 | MP0002998_abnormal_bone_remodeling | 0.78931272 |
| 131 | MP0000470_abnormal_stomach_morphology | 0.77411476 |
| 132 | MP0005451_abnormal_body_composition | 0.76324069 |
| 133 | MP0003866_abnormal_defecation | 0.76205801 |
| 134 | MP0000678_abnormal_parathyroid_gland | 0.75250884 |
| 135 | MP0005085_abnormal_gallbladder_physiolo | 0.75107016 |
| 136 | MP0003075_altered_response_to | 0.74462647 |
| 137 | MP0005670_abnormal_white_adipose | 0.74138663 |
| 138 | MP0003633_abnormal_nervous_system | 0.73812337 |
| 139 | MP0009115_abnormal_fat_cell | 0.73754768 |
| 140 | MP0000383_abnormal_hair_follicle | 0.73659820 |
| 141 | MP0002009_preneoplasia | 0.73571608 |
| 142 | MP0002693_abnormal_pancreas_physiology | 0.73557774 |
| 143 | MP0001919_abnormal_reproductive_system | 0.71647191 |
| 144 | MP0005448_abnormal_energy_balance | 0.67989393 |
| 145 | MP0005381_digestive/alimentary_phenotyp | 0.66650183 |
| 146 | MP0001664_abnormal_digestion | 0.64351189 |
| 147 | MP0002136_abnormal_kidney_physiology | 0.61978699 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.88546245 |
| 2 | Febrile seizures (HP:0002373) | 3.83336039 |
| 3 | Obstructive sleep apnea (HP:0002870) | 3.82906244 |
| 4 | Focal motor seizures (HP:0011153) | 3.77074475 |
| 5 | Chronic otitis media (HP:0000389) | 3.63670425 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 3.29248385 |
| 7 | Optic neuritis (HP:0100653) | 3.29248385 |
| 8 | Atonic seizures (HP:0010819) | 3.17626761 |
| 9 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.98200290 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.98190578 |
| 11 | Recurrent cutaneous fungal infections (HP:0011370) | 2.98190578 |
| 12 | Recurrent abscess formation (HP:0002722) | 2.97848201 |
| 13 | Agammaglobulinemia (HP:0004432) | 2.94181143 |
| 14 | Myositis (HP:0100614) | 2.92506825 |
| 15 | Recurrent fungal infections (HP:0002841) | 2.83237342 |
| 16 | Mucopolysacchariduria (HP:0008155) | 2.78428132 |
| 17 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78428132 |
| 18 | Eczematoid dermatitis (HP:0000976) | 2.75205503 |
| 19 | Abnormality of macrophages (HP:0004311) | 2.74946246 |
| 20 | Epileptic encephalopathy (HP:0200134) | 2.73872366 |
| 21 | Panhypogammaglobulinemia (HP:0003139) | 2.73577723 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 2.71994328 |
| 23 | Orchitis (HP:0100796) | 2.69175731 |
| 24 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.65999006 |
| 25 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.65999006 |
| 26 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.65999006 |
| 27 | Focal seizures (HP:0007359) | 2.65342496 |
| 28 | Meningitis (HP:0001287) | 2.61630129 |
| 29 | Severe visual impairment (HP:0001141) | 2.60405271 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 2.59581577 |
| 31 | Dysostosis multiplex (HP:0000943) | 2.58279682 |
| 32 | Hemiplegia (HP:0002301) | 2.54462286 |
| 33 | Stomach cancer (HP:0012126) | 2.54236247 |
| 34 | Abnormality of the fingertips (HP:0001211) | 2.51521628 |
| 35 | Congenital sensorineural hearing impairment (HP:0008527) | 2.50574587 |
| 36 | Abnormality of T cell number (HP:0011839) | 2.50048272 |
| 37 | Recurrent viral infections (HP:0004429) | 2.49504444 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.48788064 |
| 39 | Obstructive lung disease (HP:0006536) | 2.48788064 |
| 40 | Abnormal hair whorl (HP:0010721) | 2.47264711 |
| 41 | Chronic sinusitis (HP:0011109) | 2.45593612 |
| 42 | Vasculitis (HP:0002633) | 2.41181053 |
| 43 | Pancreatic cysts (HP:0001737) | 2.40830791 |
| 44 | Abnormality of binocular vision (HP:0011514) | 2.38137165 |
| 45 | Diplopia (HP:0000651) | 2.38137165 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.36660088 |
| 47 | T lymphocytopenia (HP:0005403) | 2.35884516 |
| 48 | Progressive cerebellar ataxia (HP:0002073) | 2.30134780 |
| 49 | Drooling (HP:0002307) | 2.29158486 |
| 50 | Excessive salivation (HP:0003781) | 2.29158486 |
| 51 | Increased cerebral lipofuscin (HP:0011813) | 2.27679305 |
| 52 | Slow saccadic eye movements (HP:0000514) | 2.26915889 |
| 53 | Conjunctival hamartoma (HP:0100780) | 2.21469266 |
| 54 | Absence seizures (HP:0002121) | 2.21285995 |
| 55 | Encephalitis (HP:0002383) | 2.19621876 |
| 56 | Thyroiditis (HP:0100646) | 2.17158403 |
| 57 | Recurrent skin infections (HP:0001581) | 2.14630089 |
| 58 | Decreased central vision (HP:0007663) | 2.12831523 |
| 59 | Dialeptic seizures (HP:0011146) | 2.11358279 |
| 60 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.10649556 |
| 61 | Broad-based gait (HP:0002136) | 2.10500862 |
| 62 | Hypochromic anemia (HP:0001931) | 2.09712932 |
| 63 | Widely spaced teeth (HP:0000687) | 2.09639073 |
| 64 | Pendular nystagmus (HP:0012043) | 2.09613083 |
| 65 | Hyperventilation (HP:0002883) | 2.08797342 |
| 66 | Abnormality of salivation (HP:0100755) | 2.08492469 |
| 67 | Absent speech (HP:0001344) | 2.08143926 |
| 68 | Generalized tonic-clonic seizures (HP:0002069) | 2.07874086 |
| 69 | Mediastinal lymphadenopathy (HP:0100721) | 2.07572865 |
| 70 | Pulmonary infiltrates (HP:0002113) | 2.06781937 |
| 71 | Hamartoma of the eye (HP:0010568) | 2.05546277 |
| 72 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.05472094 |
| 73 | True hermaphroditism (HP:0010459) | 2.04946830 |
| 74 | Hemoptysis (HP:0002105) | 2.04176147 |
| 75 | Cellulitis (HP:0100658) | 2.03978952 |
| 76 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98664654 |
| 77 | Increased IgE level (HP:0003212) | 1.98385986 |
| 78 | Porencephaly (HP:0002132) | 1.96619283 |
| 79 | Agitation (HP:0000713) | 1.95688706 |
| 80 | Sparse lateral eyebrow (HP:0005338) | 1.95349215 |
| 81 | Keratoconjunctivitis sicca (HP:0001097) | 1.93692261 |
| 82 | Inflammation of the large intestine (HP:0002037) | 1.93512122 |
| 83 | Recurrent pneumonia (HP:0006532) | 1.91622501 |
| 84 | Clumsiness (HP:0002312) | 1.90492685 |
| 85 | Autoimmune thrombocytopenia (HP:0001973) | 1.89924843 |
| 86 | Amelogenesis imperfecta (HP:0000705) | 1.89917548 |
| 87 | Abnormality of the columella (HP:0009929) | 1.89158938 |
| 88 | Colitis (HP:0002583) | 1.89150783 |
| 89 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.89128193 |
| 90 | Verrucae (HP:0200043) | 1.88702177 |
| 91 | Papilloma (HP:0012740) | 1.88702177 |
| 92 | Abnormality of the sella turcica (HP:0002679) | 1.88034524 |
| 93 | Gastrointestinal stroma tumor (HP:0100723) | 1.88021109 |
| 94 | Protruding tongue (HP:0010808) | 1.87906025 |
| 95 | Recurrent sinusitis (HP:0011108) | 1.86565501 |
| 96 | Pancreatic fibrosis (HP:0100732) | 1.86021730 |
| 97 | Arterial tortuosity (HP:0005116) | 1.85158847 |
| 98 | Eosinophilia (HP:0001880) | 1.83536599 |
| 99 | Bone cyst (HP:0012062) | 1.83427159 |
| 100 | Abolished electroretinogram (ERG) (HP:0000550) | 1.82716278 |
| 101 | Genetic anticipation (HP:0003743) | 1.81733194 |
| 102 | Decreased circulating renin level (HP:0003351) | 1.81036239 |
| 103 | Asplenia (HP:0001746) | 1.80812246 |
| 104 | Gingivitis (HP:0000230) | 1.80380588 |
| 105 | Cystic liver disease (HP:0006706) | 1.80015944 |
| 106 | Keratoconjunctivitis (HP:0001096) | 1.79910549 |
| 107 | Furrowed tongue (HP:0000221) | 1.79369741 |
| 108 | Chronic diarrhea (HP:0002028) | 1.79003080 |
| 109 | Abnormality of the odontoid process (HP:0003310) | 1.78387202 |
| 110 | Curly hair (HP:0002212) | 1.77465245 |
| 111 | Thoracic kyphosis (HP:0002942) | 1.77292665 |
| 112 | Confusion (HP:0001289) | 1.77243267 |
| 113 | Increased corneal curvature (HP:0100692) | 1.76944655 |
| 114 | Keratoconus (HP:0000563) | 1.76944655 |
| 115 | Ureteral obstruction (HP:0006000) | 1.76580873 |
| 116 | Thickened helices (HP:0000391) | 1.76335227 |
| 117 | Neurofibrillary tangles (HP:0002185) | 1.76181499 |
| 118 | Aqueductal stenosis (HP:0002410) | 1.75736393 |
| 119 | Sleep apnea (HP:0010535) | 1.75338190 |
| 120 | Abnormality of glycolipid metabolism (HP:0010969) | 1.74517739 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.74517739 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.74517739 |
| 123 | Prostate neoplasm (HP:0100787) | 1.73684512 |
| 124 | Spontaneous hematomas (HP:0007420) | 1.73162519 |
| 125 | Gaze-evoked nystagmus (HP:0000640) | 1.73092851 |
| 126 | Abnormality of the right ventricle (HP:0001707) | 1.72851600 |
| 127 | Increased IgM level (HP:0003496) | 1.71959833 |
| 128 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.71669185 |
| 129 | Restrictive lung disease (HP:0002091) | 1.71538930 |
| 130 | Lymphopenia (HP:0001888) | 1.70983617 |
| 131 | Ureteral stenosis (HP:0000071) | 1.70800986 |
| 132 | Pustule (HP:0200039) | 1.70747186 |
| 133 | Abnormality of eosinophils (HP:0001879) | 1.70641630 |
| 134 | Tented upper lip vermilion (HP:0010804) | 1.70120755 |
| 135 | Goiter (HP:0000853) | 1.69903979 |
| 136 | Hypoplasia of the odontoid process (HP:0003311) | 1.68497284 |
| 137 | Stereotypic behavior (HP:0000733) | 1.68374038 |
| 138 | Gastrointestinal inflammation (HP:0004386) | 1.67397806 |
| 139 | Xerostomia (HP:0000217) | 1.67160437 |
| 140 | Truncal ataxia (HP:0002078) | 1.66080349 |
| 141 | Vascular tortuosity (HP:0004948) | 1.66053075 |
| 142 | Postural instability (HP:0002172) | 1.64949655 |
| 143 | Generalized hypopigmentation of hair (HP:0011358) | 1.61726967 |
| 144 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.60936525 |
| 145 | Recurrent lower respiratory tract infections (HP:0002783) | 1.60386393 |
| 146 | Leukocytosis (HP:0001974) | 1.59999794 |
| 147 | Recurrent bronchitis (HP:0002837) | 1.58629948 |
| 148 | Osteomyelitis (HP:0002754) | 1.54922865 |
| 149 | Inappropriate behavior (HP:0000719) | 1.54733281 |
| 150 | Basal ganglia calcification (HP:0002135) | 1.54229912 |
| 151 | Lip pit (HP:0100267) | 1.53898424 |
| 152 | Open mouth (HP:0000194) | 1.53828313 |
| 153 | Cheilitis (HP:0100825) | 1.53778529 |
| 154 | Stomatitis (HP:0010280) | 1.53633947 |
| 155 | Onion bulb formation (HP:0003383) | 1.53015051 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.52957908 |
| 157 | Hip dysplasia (HP:0001385) | 1.52844657 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 2.90027498 |
| 2 | NTRK3 | 2.76948185 |
| 3 | MAP3K14 | 2.75000841 |
| 4 | SIK2 | 2.71759871 |
| 5 | TNIK | 2.71211701 |
| 6 | MAP3K13 | 2.67280830 |
| 7 | CASK | 2.53272697 |
| 8 | SIK3 | 2.48193881 |
| 9 | PRPF4B | 2.31884342 |
| 10 | BLK | 2.12514232 |
| 11 | NTRK2 | 1.97296277 |
| 12 | MAP3K9 | 1.95489776 |
| 13 | MAP2K7 | 1.95309551 |
| 14 | ERN1 | 1.92836813 |
| 15 | EPHA4 | 1.90741873 |
| 16 | TRIB3 | 1.88720010 |
| 17 | IRAK1 | 1.76951626 |
| 18 | MAP4K1 | 1.70424586 |
| 19 | FES | 1.70270854 |
| 20 | JAK3 | 1.66917844 |
| 21 | TXK | 1.59445331 |
| 22 | MKNK2 | 1.55318520 |
| 23 | WNK4 | 1.53982386 |
| 24 | MAP3K3 | 1.44724796 |
| 25 | BMPR1B | 1.37365611 |
| 26 | MAP3K4 | 1.36066780 |
| 27 | CLK1 | 1.35941160 |
| 28 | AKT3 | 1.35866339 |
| 29 | MAP3K2 | 1.35637137 |
| 30 | JAK1 | 1.35094891 |
| 31 | MAPK13 | 1.31440680 |
| 32 | YES1 | 1.31249051 |
| 33 | CSK | 1.30435301 |
| 34 | MAP3K10 | 1.28445747 |
| 35 | BMPR2 | 1.27915685 |
| 36 | INSRR | 1.27506305 |
| 37 | SMG1 | 1.27320521 |
| 38 | EPHA3 | 1.26002259 |
| 39 | FGFR4 | 1.22991747 |
| 40 | IRAK3 | 1.22331163 |
| 41 | SGK2 | 1.19952268 |
| 42 | SGK3 | 1.19183390 |
| 43 | SIK1 | 1.17389179 |
| 44 | DMPK | 1.16041016 |
| 45 | PRKCH | 1.14484786 |
| 46 | MARK3 | 1.11494842 |
| 47 | TNK2 | 1.10407303 |
| 48 | TAOK3 | 1.09449628 |
| 49 | CAMK1G | 1.08525328 |
| 50 | STK11 | 1.06770119 |
| 51 | MAPKAPK3 | 1.06121156 |
| 52 | IRAK4 | 1.03032911 |
| 53 | HCK | 1.02145767 |
| 54 | MARK2 | 1.02036640 |
| 55 | SYK | 1.01754394 |
| 56 | DAPK2 | 1.01532260 |
| 57 | KSR1 | 1.01461291 |
| 58 | SGK494 | 0.99847285 |
| 59 | SGK223 | 0.99847285 |
| 60 | EPHB1 | 0.97445316 |
| 61 | PRKCQ | 0.96597977 |
| 62 | STK39 | 0.94650078 |
| 63 | PLK2 | 0.93082528 |
| 64 | TAOK1 | 0.92977162 |
| 65 | FGR | 0.92550804 |
| 66 | IRAK2 | 0.91437510 |
| 67 | PAK6 | 0.91409347 |
| 68 | NTRK1 | 0.89850438 |
| 69 | CDK5 | 0.86988294 |
| 70 | CDK8 | 0.86352707 |
| 71 | EEF2K | 0.86026225 |
| 72 | SGK1 | 0.85564644 |
| 73 | STK10 | 0.84042231 |
| 74 | MAP3K11 | 0.84011745 |
| 75 | WNK1 | 0.83792071 |
| 76 | STK38 | 0.83611853 |
| 77 | ADRBK2 | 0.83383968 |
| 78 | FGFR3 | 0.81810605 |
| 79 | PRKCZ | 0.80653496 |
| 80 | CAMKK1 | 0.80472299 |
| 81 | PKN1 | 0.77830699 |
| 82 | CDK9 | 0.74390896 |
| 83 | IKBKE | 0.73704943 |
| 84 | CDK3 | 0.69983482 |
| 85 | LCK | 0.69008869 |
| 86 | NEK9 | 0.68087441 |
| 87 | GRK1 | 0.68055862 |
| 88 | PRKD2 | 0.67150730 |
| 89 | MAP3K7 | 0.66916908 |
| 90 | MARK1 | 0.66553344 |
| 91 | GRK6 | 0.65806537 |
| 92 | RPS6KA2 | 0.65113844 |
| 93 | CAMKK2 | 0.64423613 |
| 94 | RPS6KA6 | 0.61899450 |
| 95 | CAMK4 | 0.61185627 |
| 96 | IKBKB | 0.60180702 |
| 97 | STK24 | 0.60014344 |
| 98 | TYK2 | 0.59938817 |
| 99 | MAPK12 | 0.59077669 |
| 100 | CAMK1D | 0.59070572 |
| 101 | LMTK2 | 0.58482572 |
| 102 | PAK3 | 0.57855284 |
| 103 | KSR2 | 0.57655984 |
| 104 | EIF2AK2 | 0.57177616 |
| 105 | ACVR1B | 0.56811081 |
| 106 | TEC | 0.55423029 |
| 107 | GRK7 | 0.54966425 |
| 108 | PRKD3 | 0.54640772 |
| 109 | TAF1 | 0.54509925 |
| 110 | MAP2K4 | 0.54182340 |
| 111 | MELK | 0.53856504 |
| 112 | PRKCE | 0.53716851 |
| 113 | BRD4 | 0.53292087 |
| 114 | CSF1R | 0.53052902 |
| 115 | MAP3K6 | 0.52850646 |
| 116 | MAPKAPK2 | 0.51925060 |
| 117 | RPS6KC1 | 0.51535752 |
| 118 | RPS6KL1 | 0.51535752 |
| 119 | CHUK | 0.50746685 |
| 120 | ZAP70 | 0.49671540 |
| 121 | PTK6 | 0.49629400 |
| 122 | BTK | 0.49390725 |
| 123 | HIPK2 | 0.49077209 |
| 124 | CAMK1 | 0.49074415 |
| 125 | ALK | 0.49072916 |
| 126 | PNCK | 0.48929288 |
| 127 | NLK | 0.48242448 |
| 128 | DYRK2 | 0.47449519 |
| 129 | LYN | 0.47444585 |
| 130 | ITK | 0.47312599 |
| 131 | CDC42BPA | 0.46702532 |
| 132 | FYN | 0.46127938 |
| 133 | MAP3K1 | 0.44139130 |
| 134 | CDK12 | 0.42818571 |
| 135 | MAPK10 | 0.42595147 |
| 136 | DYRK1A | 0.40823309 |
| 137 | TBK1 | 0.40812604 |
| 138 | RAF1 | 0.40254838 |
| 139 | LATS1 | 0.39635297 |
| 140 | MAP2K6 | 0.39528304 |
| 141 | FRK | 0.37924452 |
| 142 | ABL1 | 0.37573944 |
| 143 | BCR | 0.37239069 |
| 144 | STK3 | 0.34646537 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 2.28583451 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92991273 |
| 3 | Morphine addiction_Homo sapiens_hsa05032 | 1.73238612 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.69698695 |
| 5 | Taste transduction_Homo sapiens_hsa04742 | 1.61553255 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.59574029 |
| 7 | Asthma_Homo sapiens_hsa05310 | 1.58962437 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.54283361 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 1.48254592 |
| 10 | Long-term potentiation_Homo sapiens_hsa04720 | 1.46623383 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.43115167 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.36634841 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.36567660 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.34716360 |
| 15 | GABAergic synapse_Homo sapiens_hsa04727 | 1.33523699 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.33079537 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.30028433 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.29385285 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.27726782 |
| 20 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.27256804 |
| 21 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25353930 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.25270255 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.24938668 |
| 24 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23657936 |
| 25 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23602396 |
| 26 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.21224555 |
| 27 | Leishmaniasis_Homo sapiens_hsa05140 | 1.20403327 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.18788250 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16694495 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.14620751 |
| 31 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13703150 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.13561442 |
| 33 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.11874405 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11677659 |
| 35 | Hepatitis C_Homo sapiens_hsa05160 | 1.11279405 |
| 36 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10980643 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.09990168 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09627421 |
| 39 | Renin secretion_Homo sapiens_hsa04924 | 1.09401813 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.08925056 |
| 41 | Tuberculosis_Homo sapiens_hsa05152 | 1.08903245 |
| 42 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.08085417 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.06352470 |
| 44 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05911292 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.05159482 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02792469 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.02010860 |
| 48 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.01614570 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01177464 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.00480999 |
| 51 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.00376640 |
| 52 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99977333 |
| 53 | Measles_Homo sapiens_hsa05162 | 0.99041027 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.98709608 |
| 55 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.98260371 |
| 56 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.95889017 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.95669713 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.95247575 |
| 59 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94438367 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.93305960 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92182505 |
| 62 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92106104 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91815858 |
| 64 | Axon guidance_Homo sapiens_hsa04360 | 0.91500993 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.91228339 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89774438 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89537937 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.88941535 |
| 69 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88518395 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.88407569 |
| 71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.88341197 |
| 72 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88055971 |
| 73 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87709536 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86418070 |
| 75 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.86143569 |
| 76 | Glioma_Homo sapiens_hsa05214 | 0.84999374 |
| 77 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84969358 |
| 78 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84668648 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83250089 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82576561 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.82376536 |
| 82 | Cocaine addiction_Homo sapiens_hsa05030 | 0.82373212 |
| 83 | Insulin resistance_Homo sapiens_hsa04931 | 0.81428213 |
| 84 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.81310852 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80864520 |
| 86 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.80276936 |
| 87 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79829537 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79214178 |
| 89 | Lysosome_Homo sapiens_hsa04142 | 0.79118118 |
| 90 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78763243 |
| 91 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76264037 |
| 92 | Phototransduction_Homo sapiens_hsa04744 | 0.75724252 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75132485 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.73783004 |
| 95 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.73654306 |
| 96 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73540721 |
| 97 | Malaria_Homo sapiens_hsa05144 | 0.73214955 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.72886261 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.72571049 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.72225988 |
| 101 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.71600969 |
| 102 | Salmonella infection_Homo sapiens_hsa05132 | 0.70608693 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70529887 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.70343576 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.69616645 |
| 106 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67382693 |
| 107 | Platelet activation_Homo sapiens_hsa04611 | 0.67370413 |
| 108 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.66251932 |
| 109 | Hepatitis B_Homo sapiens_hsa05161 | 0.65919985 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64684169 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.64294049 |
| 112 | Phagosome_Homo sapiens_hsa04145 | 0.64135023 |
| 113 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.64094090 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63789512 |
| 115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.62719710 |
| 116 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.62568108 |
| 117 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62542278 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.62502119 |
| 119 | Pertussis_Homo sapiens_hsa05133 | 0.62447897 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61779131 |
| 121 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60242855 |
| 122 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.59133987 |
| 123 | Shigellosis_Homo sapiens_hsa05131 | 0.58428060 |
| 124 | Endocytosis_Homo sapiens_hsa04144 | 0.58341573 |
| 125 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56792995 |
| 126 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53764601 |
| 127 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53602100 |
| 128 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.52388487 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.51394735 |
| 130 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.50181101 |
| 131 | Histidine metabolism_Homo sapiens_hsa00340 | 0.49253210 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48648512 |

